author-photo

Claus Kamby

Copenhagen University Hospital

92

Papers

3727

Citations

Citation Trend

Filter By

Papers (69) Sort By

Journal Conference Others

Radiation-Induced Toxicity Risks in Photon Versus Proton Therapy for Synchronous Bilateral Breast Cancer

2021
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of metastatic spinal cord compression

2021 Ugeskrift for Læger
Show All
- Source
- Cite
- Save
Citations (0)
OC-0326: DBCG-IMN: Long-term survival gain with internal mammary node irradiation to breast cancer patients

2020 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The DBCG RT NATURAL trial: Accelerated partial breast irradiation versus no irradiation for early stage breast cancer, a clinically controlled randomized phase III trial

2018
Show All
- Source
- Cite
- Save
Citations (1)
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study

2017 Clinical and Translational Radiation Oncology
Show All
- Source
- Cite
- Save
Citations (4)
PO-0898: Automated segmentation for breast cancer radiation therapy based on the ESTRO delineation guideline

2017 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PO-0891: Quality assessment of target volume delineation and dose planning in the Skagen Trial 1

2017 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1

2017 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Gemcitabine plus docetaxel versus docetaxel in patients (pts) with HER2-negative locally advanced or metastatic breast cancer (MBC): A randomized phase III study

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)